For the quarter ending 2025-09-30, PSTV made $1,397K in revenue. -$4,423K in net income. Net profit margin of -316.61%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 1,397 | 1,390 | 1,456 | 1,456 |
| Research and development | 2,436 | 1,246 | 2,574 | 2,858 |
| General and administrative | 3,443 | 1,682 | 2,514 | 2,397 |
| Total operating expenses | 5,879 | 2,928 | 5,088 | 5,255 |
| Operating loss | -4,482 | -1,538 | -3,632 | -3,799 |
| Change in fair value of warrants | - | - | -1,565 | -960 |
| Warrant issuance costs | - | - | 144 | 54 |
| Interest expense | - | - | 39 | 61 |
| Interest income | 59 | 27 | 64 | 80 |
| Financing expenses | - | -150 | - | - |
| Financing expense | - | - | 591 | - |
| Change in fair value of derivative instruments | - | -6,512 | - | - |
| Total other income (expense) | 59 | 6,689 | 264 | 925 |
| Net loss | -4,423 | 5,151 | -3,368 | -2,874 |
| Earnings per share basic | -0.04 | 0.02 | -0.527 | -0.37 |
| Earnings per share diluted | -0.04 | -0.01 | -0.657 | -0.37 |
| Weighted average number of diluted shares outstanding | 107,428,969 | 209,154,994 | -51,663 | 7,855,763 |
| Weighted average number of shares outstanding basic | 107,428,969 | 48,388,862 | -405,170.667 | 7,855,763 |
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)